
Complement 1
Empowering cancer patients with expert-led sessions on exercise, nutrition, and well-being to enhance recovery and long-term health.
Date | Investors | Amount | Round |
---|---|---|---|
* | $16.0m | Seed | |
Total Funding | 000k |
Related Content
Complement 1 focuses on improving health outcomes for cancer patients through expert-led, one-on-one live sessions that cover exercise, nutrition, and overall well-being. The company operates in the healthcare sector, specifically targeting cancer survivors who seek to enhance their recovery and long-term health beyond traditional treatments like surgery and chemotherapy. Complement 1's business model revolves around providing a clinically validated adjunct lifestyle modification program, which is trauma-informed and designed to reduce cancer recurrence and mortality by 30-35%. The program addresses the gap in lifestyle care for cancer patients, offering personalized and daily human connection to help patients stay on track. Complement 1 generates revenue by offering these specialized sessions, which are not intended to replace medical treatments but to complement them. The company serves a niche market of cancer survivors who are often left to navigate post-treatment life on their own, providing them with the tools and support needed to improve their quality of life. Keywords: cancer, health outcomes, exercise, nutrition, well-being, recovery, lifestyle modification, personalized care, cancer survivors, adjunct program.